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C ongenital toxoplasmosis results from a primary maternal infection during or in the weeks immediately preceding pregnancy. In uncontrolled studies, maternal therapy for acute infection appears to reduce the incidence and severity of fetal disease (1) . More recently published data suggest very encouraging results from therapy for infected infants with a combination of drugs including pyrimethamine, sulfadiazine and folinic acid. A substantial reduction in auditory and cognitive morbidity has been noted in comparison with historical controls (2) . Although most infected infants are asymptomatic at birth, nearly all will have chorioretinitis and other neurological defects before 20 years of age (3, 4) . Even at birth, approximately 40% of these asymptomatically infected infants have chorioretinitis or cerebral calcifications, if investigated opthalmologically and with cranial imaging (5) .
To identify all infected fetuses or infants early in life when therapy appears to be effective requires a screening program to identify either infected mothers during pregnancy or their infants at birth. Before introduction of either program, knowledge of the incidence of the disease is required so that the cost per case detected can be determined. High seroprevalence in a population indirectly suggests a high rate of acquisition that would be important during the child-bearing years. We therefore undertook a study of a population of Toronto day care providers for whom we had banked sera and a computerized data base, including date and country of birth from an earlier cytomegalovirus (CMV) survey, to determine the seroprevalence of toxoplasmosis.
METHODS

Informed consent:
Providers from 38 infant-toddler centres in Toronto, Ontario who had participated in a study of CMV seroprevalence were considered eligible. Information about the study was provided and informed consent obtained at the centre or by telephone. Consent was obtained at the centre if providers worked at centres where the research nurse was returning (to obtain blood from CMV-negative staff for seroconversion) or by telephone, if providers worked at centres where visits were not required by the research nurse. Information regarding the study was mailed to the centre before the visit or telephone call to obtain consent. Computerized data regarding day care providers: Data regarding the providers' personal history including country of birth, language spoken at home, age, day care employment history and information about hygienic practices had been obtained through a self-administered questionnaire and entered into a computerized database at The Hospital for Sick Children in Toronto, Ontario. Banked blood samples: Sera remaining from the CMV seroprevalence study had been stored at -20 o C at The Hospital for Sick Children. Serological testing: Toxoplasmosis testing was undertaken at the Ontario Provincial Laboratory in Toronto, Ontario, with screening by Latex Agglutination (Toxotest MT, Tanabe, California) and confirmation by immunofluorescent antibody (IFA) (GenBio, General Biometrics, California). A positive test was reported if the result was greater than 1:16.
Statistical analysis:
Relationships between seropositivity and providers were explored using the c 2 statistic (Fisher's exact c 2 where sample sizes were small) and odds ratio (OR) with 95% CI. All analysis was carried out using SAS statistical software.
RESULTS
Computerized data were available for 206 day care providers who had direct contact with infants and toddlers for more than 10 h/week. Consent for testing was provided and sera obtained in 1993 were available for 124 providers (60.2%). There were no significant differences between the study group and the other 40% of the providers in the original study (P>0.25 for all demographic and work-related variables). Sixteen providers tested positive for a seroprevalence of 13%. Of the 123 providers for whom country of birth was provided, 72 were born in Canada and 51 were born outside of Canada; the respective seroprevalence was 8.2% and 19.6% (P=0.067, OR 2.68, 95% CI 0.91, 7.94). Seroprevalence by region of birth is shown in Table 1 and the descending order of seroprevalence is South America, Europe, Asia, the Caribbean and North America.
Although seropositive providers were somewhat older than seronegative providers (mean 33.3 years versus 30.5 years), the range of age was similar in the two groups (19 to 55 years versus 18 to 53 years) and there was no significant association of seropositivity with age. Of those under 30 years of age, 11.7% were seropositive, compared with 15.1% age 30 years and over (P=0.6). Although the proportion of those born in Canada was not different for those over and under age 30 years (P=0.35), the association of seropositivity with country of birth was different for the two age groups. Among the 69 younger providers, seropositivity was 4.6% in the Canadianborn providers and 23.1% in those born outside of Canada (P=0.02, OR 6.5, 95% CI 1.14, 33.24). Among the 52 older providers, the respective seropositivity rates were 14.3% and 16.7% (P=0.4, OR 1.2, 95% CI 0.27, 5.42).
In this day care provider population, there was no significant relationship of seropositivity with work history (employment in child care five years or more, employment at present centre less than 1.5 years, working with infants only), size of the child care centre (25 children or more) or hygienic factors (gloves not worn during diaper changes in day care, cloth ver- 
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DISCUSSION
Our results suggest an overall low seroprevalence of toxoplasma antibody of 12.9% in this urban, Canadian-born population. Only 4.6% of Canadian-born providers under age 30 years had toxoplasma antibody. There is, however, a greater seroprevalence in those providers born outside of Canada (19.6%), particularly among those who are under 30 years of age (23.1%). In general, infection rates of toxoplasmosis vary widely and depend on factors including culinary practices and geographic location. While a possible tendency to use previously frozen meat, rather than fresh meat, for cooking may explain such differences, the study was not designed to ascertain this information.
Until the mid-1980s, six studies of seroprevalence undertaken in Canada suggested that the prevalence of antibody is approximately 20% to 40%, with higher rates among francophone or immigrant women, presumably because of culinary differences (6, 7) . In a more recent study of children in Halifax, Nova Scotia, cat ownership was associated with antibodies to Toxoplasma gondii in rural children (8) . This suggests a possible risk to susceptible pregnant rural women who have cats.
Among vegetarian and nonvegetarian members of different ethnic communities in the lower Fraser Valley of British Columbia, 20.7% had antibody when tested by ELISA immunoglobulin G in a 1994 report (7) . There was no difference between Caucasian and nonCaucasian participants or between cat owners and those without cats. There was a significantly higher prevalence (25%) among participants whose occupations were associated with handling of meat and/or cats or who had consumed raw milk. The risk of toxoplasmosis was significantly higher in Caucasians born outside of the country, in Moslems and in Orientals. Eighty per cent of females of all ethnic origins between the ages of 17 and 40 were seronegative (7) .
Wide geographic variation in rates of toxoplasmosis infection is well known. Seroprevalence relates more closely to country of birth rather than ethnic origin so that rates of infection are lower among North American-and British-born women than women born in Europe or Africa. Therefore, it may be expected that a diverse population will show different rates of infection, as we have found here. Seroprevalence data reflect acquisition insofar as they suggest the likelihood of infection. In this small study, acquisition appears to be fairly uncommon, at least for Canadian-born women.
In Canada, there is a lack of good data on the incidence of congenital toxoplasmosis presenting either with symptoms in the newborn period (5) or asymptomatically with later development of chorioretinitis (3, 4) . It has been suggested that 140 to 1400 cases of congenital toxoplasmosis occur per year in Canada with 79 to 280 being severely affected and the remainder having late sequelae (6) . In the United States, with an incidence of infection in pregnancy of 0.2% to 1%, the incidence of congenital toxoplasmosis is estimated between one per 1000 and one per 8000 births (9) . The lifetime preventable costs are estimated at $369 million each year (10) . We suggest that there is a need for additional epidemiologic data in Canada, on which decisions can be based about screening in pregnancy and infancy, particularly given the diverse culinary practices of a multicultural population.
